Compare · MVIS vs TMO
MVIS vs TMO
Side-by-side comparison of MicroVision Inc. (MVIS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- MVIS operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $212.69B, about 2205.7x MVIS ($96.4M).
- Over the past year, MVIS is down 81.7% and TMO is up 20.5% - TMO leads by 102.1 points.
- MVIS has been more active in the news (20 items in the past 4 weeks vs 9 for TMO).
- TMO has more recent analyst coverage (25 ratings vs 2 for MVIS).
- Company
- MicroVision Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.28-8.24%
- $572.46+8.68%
- Market cap
- $96.4M
- $212.69B
- 1M return
- -21.38%
- +21.92%
- 1Y return
- -81.66%
- +20.49%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 1996
- News (4w)
- 20
- 9
- Recent ratings
- 2
- 25
MicroVision Inc.
MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module that can support AR headsets; Interactive Display modules used in smart speakers and other devices; and Consumer Lidar used in smart home systems. In addition, it provides PicoP, a scanning technology that creates full color, high-contrast, and uniform image over the entire field-of-view from a small and thin module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was incorporated in 1993 and is headquartered in Redmond, Washington.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest MVIS
- MicroVision Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- MicroVision Announces Reverse Split of Common Stock to Support Continued Nasdaq Listing and Long-Term Growth Strategy
- SEC Form 4 filed by Director Smith Jada
- SEC Form 4 filed by Director Schabert Peter
- SEC Form 4 filed by Director Peterson Laura J.
- SEC Form 4 filed by Director Herbst Jeffrey A
- SEC Form 4 filed by Director Carlile Robert Paul
- SEC Form EFFECT filed by MicroVision Inc.
- MicroVision Appoints James Byun as Chief Commercial Officer
- Presenting on Emerging Growth Conference 94 Day 2 on July 16; Register to live stream
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports Second Quarter 2026 Results
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target